SCOPUS 정보 검색 플랫폼

Clinical and Experimental Dermatology

Volumn 33, Issue 2, 2008, Pages 148-150

Eczema and X-linked agammaglobulinaemia

(3) Hunter, H L a,c McKenna, K E a Edgar, J D M b

a ROYAL GROUP OF HOSPITALS TRUST (United Kingdom)

b ROYAL VICTORIA HOSPITAL (United Kingdom)

c ULSTER HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; EMOLLIENT AGENT; IMMUNOGLOBULIN G; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VIGAM;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; ECZEMA; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SKIN BIOPSY; WESTERN BLOTTING; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; ANEMIA; B-LYMPHOCYTES; CHILD; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ECZEMA; GENETIC DISEASES, X-LINKED; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; SEX FACTORS; TREATMENT OUTCOME;

EID: 38849109398 PISSN: 03076938 EISSN: 13652230 Source Type: Journal
DOI: 10.1111/j.1365-2230.2007.02582.x Document Type: Article

Times cited : (12)

References (10)

1
- 0029647039
- The primary immunodeficiencies
- Rosen FS, Cooper MD, Wedgewood RJP. The primary immunodeficiencies. N Engl J Med 1995 343 : 431 40.
- (1995) N Engl J Med , vol.343 , pp. 431-40
- Rosen, F.S.¹ Cooper, M.D.² Wedgewood, R.J.P.³

2
- 0029819741
- Complications of intravenous immune globulin treatment in neurologic disease
- Branagan TH, Nagle KJ, Lange DJ, Rowland LP. Complications of intravenous immune globulin treatment in neurologic disease. Neurology 1996 47 : 674 7.
- (1996) Neurology , vol.47 , pp. 674-7
- Branagan, T.H.¹ Nagle, K.J.² Lange, D.J.³ Rowland, L.P.⁴

3
- 0021812632
- X-linked agammaglobulinaemia. An analysis of 96 patients
- Lederman HM, Winklestein JA. X-linked agammaglobulinaemia. An analysis of 96 patients. Medicine 1985 64 : 145 56.
- (1985) Medicine , vol.64 , pp. 145-56
- Lederman, H.M.¹ Winklestein, J.A.²

4
- 0028207156
- Consensus on diagnosis and management of primary antibody deficiencies
- Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Br Med J 1994 308 : 581 5.
- (1994) Br Med J , vol.308 , pp. 581-5
- Chapel, H.M.¹

5
- 84970851073
- Eczema after intravenous infusion of immunoglobulin
- Barucha C, McMillan JC. Eczema after intravenous infusion of immunoglobulin. Br Med J 1987 295 : 1141.
- (1987) Br Med J , vol.295 , pp. 1141
- Barucha, C.¹ McMillan, J.C.²

6
- 0037516086
- Cyanosis after intravenous infusion of sandoglobulin in a 7 month old girl
- Wiens La Edmonds MJ. Cyanosis after intravenous infusion of sandoglobulin in a 7 month old girl. Ann Allergy 1994 72 : 66.
- (1994) Ann Allergy , vol.72 , pp. 66
- Wiens La Edmonds, M.J.¹

7
- 0029822077
- Intravenous immunoglobulin in the Guillain-Barre syndrome
- Hamdalla MMH, Hawkes CH, Spokes EG et al. Intravenous immunoglobulin in the Guillain-Barre syndrome. Br Med J 1996 313 : 1399 400.
- (1996) Br Med J , vol.313 , pp. 1399-400
- Hamdalla, M.M.H.¹ Hawkes, C.H.² Spokes, E.G.³

8
- 0030874547
- A double blind cross-over trial of intravenous immunoglobulin G in multiple sclerosis
- Sorenson PS, Wanscher B, Schreiber K et al. A double blind cross-over trial of intravenous immunoglobulin G in multiple sclerosis. Mult Scler Res 1997 3 : 145 8.
- (1997) Mult Scler Res , vol.3 , pp. 145-8
- Sorenson, P.S.¹ Wanscher, B.² Schreiber, K.³

9
- 0027522107
- Adverse effects of intravenous immunoglobulin
- Misbah SA, Chapel HM. Adverse effects of intravenous immunoglobulin. Drug Saf 1993 9 : 254 62.
- (1993) Drug Saf , vol.9 , pp. 254-62
- Misbah, S.A.¹ Chapel, H.M.²

10
- 0030873927
- Eczematous reactions to human immune globulin
- Whittam LR, Hay RJ, Hughes RAC. Eczematous reactions to human immune globulin. Br J Dermatol 1997 137 : 481 2.
- (1997) Br J Dermatol , vol.137 , pp. 481-2
- Whittam, L.R.¹ Hay, R.J.² Hughes, R.A.C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.